Chronic Obstructive Pulmonary Disease

Showing NaN - NaN of 59

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COPD Trial in Berlin, Mönchengladbach, Wiesbaden (Indacaterol 300µg, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Indacaterol 300μg
  • Placebo
  • Berlin, Germany
  • +2 more
Jul 29, 2011

COPD Trial in Worldwide (AZD1236, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Russe, Bulgaria
  • +13 more
Jul 25, 2011

COPD Trial in Worldwide (Indacaterol 150 µg, Tiotropium 18 µg, Placebo to indacaterol)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Indacaterol 150 μg
  • +3 more
  • Birmingham, Alabama
  • +211 more
Jul 22, 2011

COPD Trial in Worldwide (Indacaterol, Formoterol, Placebo to indacaterol)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Buenos Aires, Argentina
  • +182 more
Jul 22, 2011

COPD Trial in Worldwide (budesonide/formoterol, Prednisolone)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Aalbaek, Denmark
  • +36 more
Jan 21, 2011

COPD Trial in Berlin (QAK423A)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Berlin, Germany
    Novartis Investigative Site
Sep 16, 2010

COPD Trial in Berlin (AZD9668)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Berlin, Germany
    Research Site
Feb 4, 2010

Diabetes, Chronic Heart Failure, COPD Trial in Worldwide (Wireless monitors for disease specific clinical parameters.)

Unknown status
  • Diabetes Mellitus
  • +2 more
  • Wireless monitors for disease specific clinical parameters.
  • Langeland, Denmark
  • +5 more
May 7, 2009

COPD Trial in Worldwide (Budesonide/formoterol pMDI, Formoterol Turbuhaler)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Budesonide/formoterol pMDI
  • Formoterol Turbuhaler
  • Birmingham, Alabama
  • +215 more
Mar 26, 2009